Filing Details

Accession Number:
0001628280-22-030745
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-23 16:04:04
Reporting Period:
2022-11-21
Accepted Time:
2022-11-23 16:04:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600620 Aurinia Pharmaceuticals Inc. AUPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1636642 Maxwell Matthew Donley #1203-4464 Markham Street
Victoria A1 V8Z7X8
Ex Vp, Internal Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-21 10,000 $4.66 27,927 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 1,703 common stock of the Issuer acquired by the reporting person on May 31, 2022 pursuant to the Company's 2021 Employee Stock Purchase Plan.